Colossal Biosciences Eyes Major New Funding at Up to $30 Billion Valuation
Colossal Biosciences is reportedly seeking new funding at a $20B-$30B valuation as its de-extinction science, spinouts, and revenue model gain momentu...
We use cookies to improve your experience and analyze site traffic.
Privacy Policy
Cookie Preferences
Essential Cookies
Required for the site to function properly. These cookies cannot be disabled.
Always On
Analytics Cookies
Help us understand how visitors use our site to improve your experience. (Google Analytics)